Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dewilde

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
European Heart Journal. Cardiovascular Pharmacotherapy|June 18, 2021
Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trialsAlexander P Benz, Isabelle Johansson, Willem J M Dewilde, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 1, 2022
The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary interventionA J W M de Veer, N Bennaghmouch, W L Bor, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 28, 2014
Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trialWillem J M Dewilde, Paul W Janssen, Johannes C Kelder, et al.
Lancet (London, England)|February 19, 2013
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trialWillem J M Dewilde, Tom Oirbans, Freek W A Verheugt, et al.
Thrombosis Research|July 21, 2020
Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysisAntonia Sambola, Pau Rello, Toni Soriano, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 4, 2022
Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 StudyWillem Lambertus Bor, Anne Johanna Wilhelmina de Veer, Renske H Olie, et al.
American Heart Journal|June 23, 2014
CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics studyThomas O Bergmeijer, Paul W A Janssen, Jurjan C Schipper, et al.
Circulation. Cardiovascular Interventions|March 16, 2021
Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics SubanalysisDaniel M F Claassens, Thomas O Bergmeijer, Gerrit J A Vos, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 7, 2021
Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics TrialDaniel M F Claassens, Pim W M van Dorst, Gerrit J A Vos, et al.
The New England Journal of Medicine|September 4, 2019
A Genotype-Guided Strategy for Oral P2Y<sub>12</sub> Inhibitors in Primary PCIDaniel M F Claassens, Gerrit J A Vos, Thomas O Bergmeijer, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
European Heart Journal. Cardiovascular Pharmacotherapy|June 18, 2021
Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trialsAlexander P Benz, Isabelle Johansson, Willem J M Dewilde, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 1, 2022
The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary interventionA J W M de Veer, N Bennaghmouch, W L Bor, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 28, 2014
Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trialWillem J M Dewilde, Paul W Janssen, Johannes C Kelder, et al.
Lancet (London, England)|February 19, 2013
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trialWillem J M Dewilde, Tom Oirbans, Freek W A Verheugt, et al.
Thrombosis Research|July 21, 2020
Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysisAntonia Sambola, Pau Rello, Toni Soriano, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 4, 2022
Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 StudyWillem Lambertus Bor, Anne Johanna Wilhelmina de Veer, Renske H Olie, et al.
American Heart Journal|June 23, 2014
CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics studyThomas O Bergmeijer, Paul W A Janssen, Jurjan C Schipper, et al.
Circulation. Cardiovascular Interventions|March 16, 2021
Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics SubanalysisDaniel M F Claassens, Thomas O Bergmeijer, Gerrit J A Vos, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 7, 2021
Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics TrialDaniel M F Claassens, Pim W M van Dorst, Gerrit J A Vos, et al.
The New England Journal of Medicine|September 4, 2019
A Genotype-Guided Strategy for Oral P2Y<sub>12</sub> Inhibitors in Primary PCIDaniel M F Claassens, Gerrit J A Vos, Thomas O Bergmeijer, et al.
Pageof 2